HIPK2 and non-small cell lung carcinoma: Although miR-1260b treatment did not affect cell proliferation in NSCLC cells (Fig. S5), HIPK2 suppression by shRNA or miR-1260b significantly enhanced the migration and invasiveness of NSCLC cells, whereas miR-1260b did not affect the ability to cellular mobility under reduced HIPK2 expression (Figs S6 and 2B, C).